Squarepoint
TECX

Squarepoint’s Tectonic Therapeutic TECX Stock Holding History

Squarepoint’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99M Sell
145,028
-19,391
-12% -$570K 0.01% 1605
2026
Q1 		$5.08M Sell
164,419
-35,227
-18% -$867K 0.01% 1489
2025
Q4 		$4.16M Buy
199,646
+134,211
+205% +$2.49M ﹤0.01% 1569
2025
Q3 		$1.03M Sell
65,435
-19,934
-23% -$411K ﹤0.01% 2669
2025
Q2 		$1.7M Buy
85,369
+32,472
+61% +$658K ﹤0.01% 2219
2025
Q1 		$937K Buy
+52,897
New +$1.72M ﹤0.01% 2733
2024
Q2 		– Sell
-3,225
Closed -$49.5K – 4755
2024
Q1 		$49.5K Buy
+3,225
New +$51.1K ﹤0.01% 3878
2021
Q4 		– Sell
-2,493
Closed -$167K – 3590
2021
Q3 		$167K Buy
2,493
+722
+41% +$59.2K ﹤0.01% 2556
2021
Q2 		$189K Sell
1,771
-5,791
-77% -$686K ﹤0.01% 2858
2021
Q1 		$1.15M Buy
7,562
+5,077
+204% +$826K 0.01% 1400
2020
Q4 		$416K Sell
2,485
-1,451
-37% -$258K ﹤0.01% 1947
2020
Q3 		$615K Sell
3,936
-2,245
-36% -$452K 0.01% 1279
2020
Q2 		$1.29M Buy
6,181
+4,131
+202% +$851K 0.02% 812
2020
Q1 		$383K Sell
2,050
-2,133
-51% -$502K 0.01% 1179
2019
Q4 		$1.01M Buy
4,183
+1,805
+76% +$348K 0.01% 1329
2019
Q3 		$403K Buy
+2,378
New +$538K ﹤0.01% 1734
2019
Q1 		– Sell
-906
Closed -$181K – 2492
2018
Q4 		$181K Buy
+906
New +$276K ﹤0.01% 1716

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Squarepoint's TECX Position: Q2 2026 in Review

Squarepoint reduced its Tectonic Therapeutic (TECX) stake by 12% in Q2 2026, selling an estimated $570K and leaving 145,028 shares worth $4.99M. The position accounts for 0.01% of the portfolio, ranked #1605.

Squarepoint first reported a position in TECX in Q4 2018 and has held it in 17 quarters since. The position peaked at $5.08M in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Squarepoint held 145,028 shares of Tectonic Therapeutic worth $4.99M as of Q2 2026.
  • Squarepoint sold 19,391 Tectonic Therapeutic shares in Q2 2026, an estimated $570K.
  • Tectonic Therapeutic made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1605 holding.
  • Squarepoint first reported a position in Tectonic Therapeutic in Q4 2018 and has held it in 17 quarters since.
  • Squarepoint's Tectonic Therapeutic position peaked at $5.08M in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.